M Holdings Securities’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.65M Sell
101,348
-35,456
-26% -$944K 0.18% 105
2025
Q4
$3.41M Buy
136,804
+119,508
+691% +$3.01M 0.24% 77
2025
Q3
$441K Buy
+17,296
New +$427K 0.09% 79
2025
Q2
Sell
-79,018
Closed -$2M 197
2025
Q1
$2M Sell
79,018
-1,798
-2% -$47K 0.33% 62
2024
Q4
$2.14M Buy
+80,816
New +$2.19M 0.35% 58
2024
Q2
Sell
-40,440
Closed -$1.12M 338
2024
Q1
$1.12M Sell
40,440
-13,411
-25% -$372K 0.19% 75
2023
Q4
$1.55M Sell
53,851
-9,935
-16% -$300K 0.18% 89
2023
Q3
$2.12M Buy
63,786
+51,960
+439% +$1.84M 0.28% 67
2023
Q2
$434K Buy
+11,826
New +$460K 0.09% 119
2023
Q1
Sell
-65,897
Closed -$2.85M 555
2022
Q4
$3.38M Buy
65,897
+1,081
+2% +$51.8K 0.36% 57
2022
Q3
$2.84M Sell
64,816
-425
-0.7% -$20.7K 0.31% 71
2022
Q2
$3.42M Sell
65,241
-1,290
-2% -$65.7K 0.35% 65
2022
Q1
$3.44M Buy
+66,531
New +$3.45M 0.26% 76
2021
Q2
$2.65M Sell
67,620
-26
-0% -$1.01K 0.26% 87
2021
Q1
$2.45M Buy
67,646
+9,485
+16% +$337K 0.22% 97
2020
Q4
$2.14M Sell
58,161
-2,131
-4% -$78.2K 0.27% 77
2020
Q3
$2.1M Buy
60,292
+2,417
+4% +$84.7K 0.33% 72
2020
Q2
$1.8M Sell
57,875
-26,436
-31% -$898K 0.32% 79
2020
Q1
$2.61M Buy
84,311
+29,054
+53% +$990K 0.39% 76
2019
Q4
$2.05M Sell
55,257
-3,161
-5% -$113K 0.6% 54
2019
Q3
$1.99M Buy
58,418
+3,187
+6% +$116K 0.61% 51
2019
Q2
$2.27M Buy
55,231
+13,228
+31% +$525K 0.77% 37
2019
Q1
$1.69M Buy
42,003
+9,162
+28% +$367K 0.39% 68
2018
Q4
$1.36M Buy
32,841
+1,861
+6% +$77.3K 0.42% 59
2018
Q3
$1.29M Buy
30,980
+946
+3% +$36.4K 0.34% 74
2018
Q2
$1.03M Buy
30,034
+3,195
+12% +$109K 0.28% 99
2018
Q1
$904K Sell
26,839
-700
-3% -$24.1K 0.28% 112
2017
Q4
$946K Sell
27,539
-236
-0.8% -$8.05K 0.29% 106
2017
Q3
$941K Buy
27,775
+333
+1% +$10.7K 0.3% 94
2017
Q2
$875K Buy
27,442
+8,047
+41% +$254K 0.3% 96
2017
Q1
$629K Buy
19,395
+2,523
+15% +$79.5K 0.24% 116
2016
Q4
$520K Sell
16,872
-4,013
-19% -$123K 0.18% 128
2016
Q3
$671K Sell
20,885
-249
-1% -$8.33K 0.31% 95
2016
Q2
$706K Buy
21,134
+6,608
+45% +$211K 0.36% 78
2016
Q1
$408K Buy
14,526
+1,704
+13% +$48.7K 0.25% 120
2015
Q4
$393K Sell
12,822
-1,874
-13% -$59K 0.26% 112
2015
Q3
$438K Sell
14,696
-2,617
-15% -$83.9K 0.31% 98
2015
Q2
$551K Buy
17,313
+707
+4% +$23K 0.37% 80
2015
Q1
$548K Sell
16,606
-2,007
-11% -$63.8K 0.36% 84
2014
Q4
$550K Buy
18,613
+1,531
+9% +$43.9K 0.36% 85
2014
Q3
$496K Sell
17,082
-4,230
-20% -$119K 0.28% 87
2014
Q2
$600K Buy
21,312
+8,949
+72% +$255K 0.38% 74
2014
Q1
$377K Sell
12,363
-2,189
-15% -$65.3K 0.4% 69
2013
Q4
$423K Buy
+14,552
New +$424K 0.3% 88

Other funds holding PFE

M Holdings Securities's PFE Position: Q1 2026 in Review

M Holdings Securities reduced its Pfizer (PFE) stake by 26% in Q1 2026, selling an estimated $944K and leaving 101,348 shares worth $2.65M. The position accounts for 0.18% of the portfolio, ranked #105.

M Holdings Securities first reported a position in PFE in Q4 2013 and has held it in 44 quarters since. The position peaked at $3.44M in Q1 2022. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • M Holdings Securities held 101,348 shares of Pfizer worth $2.65M as of Q1 2026.
  • M Holdings Securities sold 35,456 Pfizer shares in Q1 2026, an estimated $944K.
  • Pfizer made up 0.18% of M Holdings Securities's portfolio in Q1 2026, its #105 holding.
  • M Holdings Securities first reported a position in Pfizer in Q4 2013 and has held it in 44 quarters since.
  • M Holdings Securities's Pfizer position peaked at $3.44M in Q1 2022.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on M Holdings Securities's 13F filing for Q1 2026, filed 12 May 2026.